Eventide Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $1.79 Million - $2.46 Million	53,200 Added 17.4%	359,000 $16.6 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $12.2 Million - $20.2 Million	305,800 New	305,800 $12.7 Million
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $3.4 Million - $6.76 Million	-87,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$49.79 - $66.32 $4.35 Million - $5.8 Million	87,400	87,400 $4.66 Million

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.